Active Government Funding Opportunities

The Army seeks clinical trial research to advance traumatic brain injury and psychological health treatments for service members. This funding supports evidence-based interventions to improve diagnosis, prevention, and recovery outcomes.

DoD seeks development of a multiomic atlas from human bone marrow failure samples to create an open-access research resource. This dataset will enable discoveries advancing understanding of bone marrow failure diseases across the research and clinical community.

NSF FINDERS FOUNDRY supports K-12 educators, technologists, and researchers collaborating to develop AI-integrated learning solutions and tools. Teams co-design evidence-based technologies addressing real challenges identified by students and educators to prepare the workforce for an AI-driven future.

This DoD funding supports innovative research to transform Alzheimer's diagnosis and disease monitoring. Projects must demonstrate non-incremental solutions that overcome barriers to diagnosis and prognosis, with preliminary data and community collaboration required.

Accelerate cancer treatment breakthroughs through clinical trials testing new drugs, devices, and emerging therapies. This award funds rapid-cycle trials from proof-of-concept to phase III, addressing the urgent need to translate promising cancer interventions into patient care.

This DoD program funds clinical research and trials testing new care interventions for Alzheimer's disease and related dementia. Projects must demonstrate preliminary data, involve community collaboration, and address practical care solutions beyond drug testing.

DoD seeks innovative, high-risk cancer research concepts to advance treatment options and patient outcomes for Service Members and military beneficiaries. Preliminary data not required; creative thinking and untested ideas addressing unmet clinical needs are prioritized.

Supports transformative research to identify and validate risk factors for Alzheimer's disease and develop prevention strategies. Projects must advance understanding of environmental, genetic, or lifestyle risks and propose actionable solutions to reduce AD/ADRD development.

The Army seeks clinical trial research to advance vision capabilities and treatments. This opportunity supports innovative medical studies addressing soldier visual performance and eye health.

Mature cancer research with near-term clinical impact for military health systems. Supports studies including clinical trials addressing congressionally directed priorities in oncology.

Support innovative, high-risk MS research concepts at early exploration stages through hypothesis development. This award funds groundbreaking studies that establish foundations for future scientific investigation, with no preliminary data required.

Accelerate drug discovery and therapeutic development for hearing restoration following military-relevant auditory injury. This program supports preclinical and clinical research to restore hearing function in service members.

DoD seeks interventional lupus research with near-term health impact, including clinical trials and health system innovations. Teams must include patient advocates and provide preliminary data demonstrating feasibility and potential quality-of-life improvements.

DoD seeks translational arthritis research that bridges preclinical findings into clinical solutions for Service Members and Veterans. Projects must demonstrate high-impact, hypothesis-driven applied research with preliminary data and clear pathways to real-world medical applications.

NSF seeks proposals to develop and operate national-scale cyberinfrastructure systems that enable data-intensive and AI-driven research across science and engineering disciplines. Projects will create integrated data services to advance open science innovation and education.

Support rigorous, investigator-initiated research projects advancing Multiple Sclerosis understanding and patient outcomes. Funding available for laboratory, clinical, and population-based studies with preliminary data, including dedicated tracks for early-career investigators.

DoD seeks breakthrough breast cancer research with high clinical potential, supporting projects from preclinical through early clinical stages. Applications must address priority research challenges and include consumer advocates as core team members.

Support early-stage researchers investigating Multiple Sclerosis through independent, mentor-guided projects. This award develops the next generation of MS researchers by funding novel research questions and advancing scientific careers in neuroimmunology.

DoD seeks innovative, high-risk lupus research addressing critical gaps in disease understanding and treatment. Early-career researchers can propose novel ideas with or without preliminary data, emphasizing breakthrough discoveries over incremental advances.

NSF CISE supports foundational research across 11 computing domains—from algorithms and AI to cybersecurity and human-centered computing. This program funds novel R&D projects that advance knowledge in computing systems, communications, and information science to drive future technological breakthroughs.

Develop secure AI-native capabilities for Radio Access Networks (RAN) that enable operators to generate revenue and reduce costs through innovative services. The program seeks demonstrations of commercial viability and export-ready open, interoperable solutions.

This DoD clinical research award funds studies evaluating arthritis prevention, early diagnosis, and treatment approaches. Research generates evidence to optimize patient outcomes and inform clinical care through pilot studies or full-scale clinical trials with community collaboration.

This DoD funding accelerates spinal cord injury research from promising ideas to clinical applications through translational research. It supports early-career partnerships and requires community engagement to ensure real-world relevance.

This DoD funding supports high-risk, high-reward lupus research with potential for major scientific impact. Researchers can pursue innovative approaches addressing priority focus areas without requiring preliminary data.

Develop and validate clinical biomarkers and outcome measures to improve ALS clinical trials, including digital health tools like wearables and AI-enabled monitoring. Projects should incorporate patient community input and may target specific ALS subtypes or therapeutic classes.